[Clinical knowledge of the secondary effects of gold salts].
D006051:Aurothioglucose / Q000009:adverse effects; D001991:Bronchitis / Q000139:chemically induced; D003873:Dermatitis, Exfoliative / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology; D004342:Drug Hypersensitivity / Q000276:immunology; D004492:Edetic Acid / Q000627:therapeutic use; D004802:Eosinophilia / Q000139:chemically induced; D006046:Gold / Q000009:adverse effects*; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D008010:Lichen Planus / Q000139:chemically induced; D008213:Lymphocyte Activation; D009393:Nephritis / Q000139:chemically induced; D009503:Neutropenia / Q000139:chemically induced; D010915:Pityriasis / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D006051:Aurothioglucose; D007073:Immunoglobulin E; D006046:Gold; D004492:Edetic Acid
Connaissance clinique des effets secondaires des sels d'or